Wright Medical Group (WMGI) : Traders are bullish on Wright Medical Group (WMGI) as it has outperformed the S&P 500 by a wide margin of 18.42% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 9.11%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 9.58% in the last 1 week, and is up 21.36% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
Wright Medical Group (NASDAQ:WMGI): The stock opened at $24.55 on Friday but the bulls could not build on the opening and the stock topped out at $24.91 for the day. The stock traded down to $23.98 during the day, due to lack of any buying support eventually closed down at $24.03 with a loss of -1.92% for the day. The stock had closed at $24.50 on the previous day. The total traded volume was 1,671,755 shares.
The stock has recorded a 20-day Moving Average of 11.41% and the 50-Day Moving Average is 22.4%. Wright Medical Group N.V. is up 28.02% in the last 3-month period. Year-to-Date the stock performance stands at -0.62%.
Wright Medical Group (WMGI) : 13 investment research analysts covering Wright Medical Group (WMGI) have an average price target of $27.08 for the near short term. The highest target price given by the Brokerage Firm to the stock is $33 and the lowest target is $22 for the short term. Analysts expect the variance to be within $3.3 of the average price.
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.